Latest News and Press Releases
Want to stay updated on the latest news?
-
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - The demand for antiviral drugs has been increasing globally due to the growing prevalence of viral...
-
BOTHELL, Wash., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing novel...
-
New York, April 06, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the antiviral drugs market size is projected to surpass around USD 71.1 billion by 2032 from USD 49.8 billion in 2022, and it is...
-
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
-
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
-
London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Antiviral Drugs Market, 2022 – 2035” report to its list of offerings. The recent COVID-19 pandemic has...
-
New York, March 16, 2022 (GLOBE NEWSWIRE) -- In his latest book, bestselling author William A. Haseltine Ph.D. tells us that understanding our natural immunity to the SARS-CoV-2 virus is critical...
-
Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...
-
Visiongain has published a new report on Antiviral Drugs Treatment Market Report 2021-2031. Profiles of Antiviral Drugs Treatment and Forecasts By Drug Class (DNA Ploymerase Inhibitors, Reverse...
-
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Antiviral Drugs Market– Global Industry Analysis, Market Size, Opportunities and...